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RCBTBe Condensation 1 (RCC1) was identiﬁed over 20 years ago as a critical cell cycle
regulator. By analyzing its amino acid sequence, RCC1 was found to consist of seven homologous repeats of
51–68 amino acid residues, which were later shown to adopt a seven-bladed β-propeller fold. Since the
initial identiﬁcation of RCC1, a number of proteins have been discovered that contain one or more RCC1-like
domains (RLDs). As we show here, these RCC1 superfamily proteins can be subdivided in ﬁve subgroups
based on structural criteria. In recent years, a number of studies have been published regarding the functions
of RCC1 superfamily proteins. From these studies, the emerging picture is that the RLD is a versatile domain
which may perform many different functions, including guanine nucleotide exchange on small GTP-binding
proteins, enzyme inhibition or interaction with proteins and lipids. Here, we review the available structural
and functional data on RCC1 superfamily members, paying special attention to the human proteins and their
involvement in disease.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe RCC1 superfamily of proteins is characterized by a 350–500
residue domain, known as the RCC1-like domain or RLD, that was ﬁrst
reported in 1987 in the Regulator of Chromosome Condensation 1,
RCC1 [1,2]. A mutated RCC1 allele was found to be responsible for the
temperature-sensitive phenotypes seen in the ts-BN2 hamster cell
lines, including premature chromosome condensation and arrest in
the G1 phase of the cell cycle. These phenotypes could be rescued by
the introduction of wild-type RCC1 [1–3]. It was not until the mid-
nineties that another human protein, HERC1, was found that con-
tained not one, but two RLDs [4]. Since then, sixteen additional human
proteins have been described that have at least one RLD in their amino
acid sequences.
In this review, we show that these proteins can be divided into ﬁve
subgroups based on their structural characteristics (Fig. 1): (1) the
RCC1 subgroup, (2) the HERC subgroup, (3) the RCBTB subgroup,
(4) the kinase subgroup and (5) the miscellaneous subgroup, encom-
passing the proteins that cannot be classiﬁed into any of the other
subgroups.
In addition, the following sections will present the available
knowledge regarding the structure and function of RCC1 superfamily
genes and proteins, with an emphasis on the humanmembers. Finally,
the involvement of RCC1 superfamily genes and proteins in patholo-
gical conditions will also be discussed.e Salk Institute for Biological
37, United States.
l rights reserved.2. RCC1 superfamily genes and proteins
The genes encoding human RLD-containing proteins (see Table 1)
are located in different chromosomes, though closer homologs tend
to be located in the vicinity of each other. Thus, the genes for RCC1
and TD-60 are close to each other in chromosome 1. Similarly,
HERC1 andHERC2 are both on the long arm of chromosome 15,where-
as HERC3, HERC5 and HERC6 are in the same region in chromosome
4 [5]. Likewise, both RCBTB1 and RCBTB2 are located on the long
arm of chromosome 13. The other genes are dispersed throughout
the genome, either on autosomes or, in the case of RPGR, in the
X chromosome.
All these genes have different exon numbers and the proteins
encoded by them range from little more than 400 amino acid residues
to close to 5000 (see Table 1). Splicing isoforms have been studied in
some cases, such as those of RCC1, DelGEF, RPGR, PAM and some HERC
proteins [6–10]. While alternative splicing of RCC1, HERC6 and PAM
does not affect the sequence of their RLDs [6,7,10], the same cannot be
said of DelGEF, RPGR and HERC4, where some of the isoforms have
truncated RLDs [7,8,11,12]. Apart from that, the Ensembl database also
predicts alternatively spliced transcripts for some of the other proteins
described here, but whether or not these isoforms actually exist has
not yet been examined [13].
Regarding the architectures of RCC1 superfamily proteins (Fig. 1),
there are instances where the RLD domainmakes up almost thewhole
protein, as is the case for RCC1 subgroup members (RCC1, TD-60,
DelGEF andWBSCR16), or it can be the only highly conserved region of
a protein, as in RPGR. In other cases, the RLD is part of more complex,
multidomain proteins. For example, RLDs can be found in proteins
involved in ubiquitination, where they are associated with HECT or
Fig. 1. Schematic representation of human RCC1 superfamily proteins. The eighteen proteins have been classiﬁed into ﬁve subgroups: (1) the RCC1 subgroup (including those proteins
whoseRLD spans almost thewhole length of the protein), (2) theHERC subgroup (proteins containing RLDandHECTdomains), (3) theRCBTB subgroup (proteins containing RLDandBTB
domains), (4) the kinase subgroup (proteins containing RLD and kinase domains) and (5) the miscellaneous subgroup, encompassing those proteins that do not ﬁt into any of the
previous categories. Dark blue rectangles represent theRLDs. All proteins anddomains are shown to scale (scale shownat bottom right side). Big proteins suchas PAM,HERC1 andHERC2
are drawn inmore than one line, with amino acid numbers shown at each end. A star on top of RCC1's RLD shows the location of the β-wedge, essential for RCC1's activity as a Ran-GEF.
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Table 1
The human RCC1 superfamily proteins
The human RCC1 superfamily
Protein names Number
of
residues
Protein/gene
accession
number
Chromosomal
location
Known
function/interaction
RLD
function
Other known
domains
References
RCC1
subgroup
RCC1 (Regulator of
Chromosome
Condensation 1),
Ran-GEF
(RLD: 18–421)
421 P18754/
NM_001269
1p36.1 Binds to chromatin
and acts as a guanine
exchange factor (GEF)
on Ras homologue Ran
G,P Nuclear localization
signal (NLS)
[1–3,15,22,
29,31,66]
TD-60 (telophase disk 60),
RCC2 (RLD: 121–507)
522 Q9P258/
NM_018715
1p36.13 Chromosomal passenger
protein involved in
mitotic progression
? NLS [28,30,77]
DelGEF (deafness
locus-associated
putative guanine nucleotide
exchange factor),
also called
SERGEF. (RLD: 4–407)
458 Q9UGK8/
NM_012139
1p14.3 Modulates secretion of
proteoglycans and interacts
with Sec5 and DelGIP1
? [8,32,33]
WBSCR16 (William–Beuren
syndrome critical region 16),
WBS16 (RLD: 56–454)
454 Q8N572/
NM_030798
7q11.23 Possible role in Williams–
Beuren syndrome
? [152]
HERC
subgroup
HERC1 (for HECT domain and RCC1)
(RLD1: 361–749; RLD2: 3990–4366)
4861 Q15751/
NM_003922
15q22 Binds clathrin heavy chain,
phosphoinositides,
ARF/Rab proteins and TSC2.
Ubiquitin ligase,
no known targets
G,P,L HECT, SPRY, WD40,
leucine zipper
[4,5,42–44,
79,80]
HERC2 (RLD1: 415–784; RLD2:
2949–3332; RLD3: 3941–4324)
4834 O95714/
NM_004667
15q13 Involved in murine
rjs syndrome.
ubiquitin ligase,
no known targets
? HECT, Mib-HERC2,
DOC domain, ZZ type
zinc ﬁnger, cyt
b5-like region
[5,34,
141–148]
HERC3 (RLD: 1–371) 1050 Q15034/
NM_014606
4q21 Ubiquitin ligase,
no known targets
? HECT [5,35,41]
HERC4 (RLD: 1–371) 1057 Q5GLZ8/
NM_015601
or
NM_022079
10q21.3 Ubiquitin ligase,
no known targets
? HECT [7,45]
HERC5 (previously known as Ceb1)
(RLD: 1–367)
1024 Q9UII4/
NM_016323
4q22.1 Mediates ISGylation of
natural ISG15 target proteins
? HECT [7,36–40]
HERC6 (RLD: 1–355) 1022 Q8IVU3/
NM_017912
4q22.1 Ubiquitin ligase,
no known targets
? HECT [7,37–40]
RCBTB
subgroup
RCBTB1 (RCC1 and BTB
containing protein 1) or
CLLD7 (RLD: 1–357)
531 Q8NDN9/
NM_018191
13q14 Possible tumor suppressor in
chronic lymphocytic leukemia
? BTB domain [154–156]
RCBTB2, also called CHC1L
(RLD: 1–372)
551 O95199/
NM_001268
13q14.3 Possible tumor suppressor in
prostate cancer
? BTB domain, BRCA
domain
[157]
IBtk (inhibitor of Bruton's
tyrosine kinase)
(RLD: 74–485)
1353 Q9P2D0/
NM_015525
6q14.1 Inhibits Btk ? BTB, ANK [52]
Kinase
subgroup
Nek9, also known as Nercc1
(RLD: 332–725)
979 Q8TD19/
NM_033116
14q24.3 Role in mitotic progression.
Binds to Ran.
P Protein kinase, CC,
PEST sequences
[46–49,
81–83]
Nek8 (RLD: 272–683) 692 Q86SG6/
NM_178170
17q11.1 Role in ciliary size and
function
? Protein kinase [46,50,51,
84–86,
135–140]
Miscellaneous
subgroup
Alsin also called ALS2
(RLD: 110–633)
1657 Q96Q42/
NM_020919
2q33.1 Rab5-GEF and Rac1 effector,
though not through RLD
domain, binds to GRIP1
G, P DH, PH, MORN, VPS9 [57–59,87–89,
125,126,134]
PAM (protein associated
with Myc) also called Myc
binding protein 2
(MYCB2)
(RLD: 552–1030)
4640 O75592/
NM_015057
13q22 Binds to Myc and inhibits
adenylyl cyclase
P RZF, 2 Zinc-ﬁngers,
Myc binding
protein, NLS
[10,60–63,
95–117]
RPGR (retinitis pigmentosa
GTPase regulator),
ORF15 (RLD: 1–372)
1020 Q92834/
NM_000328
Xp11.4 Role in ciliary function.
Linked to retinitis pigmentosa,
binds to PDEδ and RPGRIP1
P [9,11,12,
53–56,90–94]
In the RLD function column, G, P and L stand for: guanine nucleotide exchange/release factor (G), protein–protein interactions (P), and protein–lipid interactions (L). A question mark
indicates that no functions have been identiﬁed for that RLD.
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other catalytic activities, such as kinases. RLDs can also be associated
with protein–protein interaction domains such as the BTB domain
(Broad complex, Tramtrack and Bric à brac) of the RCBTB subgroup.
Concerning the RLDs themselves, these are domains of usually
around 400 amino acid residues (from355 to 411), with the exceptionsof PAM and Alsin, whose RLDs are bigger than the rest at 478 and 523
residues, respectively (Table 1). Fig. 2 shows an alignment of all
reported human RLDs, i.e. those present in the proteins shown in Fig.1.
The RLDs shown in these two ﬁgures are recognized as such by the
InterPro database (entry IPR009091) [14] and also by the Superfamily
database (entry 50985) (http://supfam.cs.bris.ac.uk/SUPERFAMILY). In
1470 O. Hadjebi et al. / Biochimica et Biophysica Acta 1783 (2008) 1467–1479the former webpage, information is available on the hidden Markov
model-based algorithm used for establishing the presence and
location of RLDs in protein sequences.
As previously described, the RLD of RCC1 is made of seven repe-
titive sequences of 51–68 amino acid residues each, which together
constitute the full domain [15]. These repeats, known as RCC1 repeats,
are deﬁned by another algorithm that can be found in the Prosite
database (entry PS50012) [16], or in InterPro (entry IPR000408) [14].
Although all RLD sequences align well with the RLD of RCC1 (Fig. 2),
not all of them contain seven RCC1 repeats according to the deﬁnition
just mentioned. Thus, while the RLDs of RCC1, DelGEF, HERC1 (both
RLDs), HERC2 (the last two RLDs), HERC3 and HERC4 all contain seven
canonical RCC1 repeats, all other RLDs contain between three and six
RCC1 repeats (PAM and IBtk have three; RCBTB2, HERC5 and the ﬁrst
RLD in HERC2 have four; TD-60, HERC6, RCBTB1, Nek8 and Alsin have
ﬁve; WBSCR16, Nek9 and RPGR have six). However, the absence of
seven canonical RCC1 repeats in these RLDs should not be interpreted
as meaning that these RLDs do not have seven repeats. As a matter of
fact, all these RLDs have sequences that correspond, both in length and
in similarity (Fig. 2), to each of the seven repeats in RCC1. Therefore,
these RLDs do indeed contain seven repeats, some of which qualify as
bona ﬁde RCC1 repeats, while the rest are non-canonical RCC1-like
repeats [17]. The next section will address the relationship between
these sequence repeats and the three-dimensional structure of these
proteins.
In Fig. 3A, a phylogenetic tree of all known human RLDs is shown.
As explained in the ﬁgure legend, this tree was generated from the
alignment in Fig. 2. Interestingly, the tree shows that the ﬁve
subgroup-based classiﬁcation mentioned earlier for RLD-containing
proteins (Fig. 1) does not accurately reﬂect the phylogenetic relation-
ships between RLDs. Thus, for the RCC1 subgroup, the RLDs of RCC1,
TD-60 and WBSCR16 are closely related, but they are very different
from that of DelGEF. Regarding the HERC subgroup, their RLDs cluster
in two separate regions, corresponding to the large (HERC1–2) and
small (HERC3–6) HERC proteins, respectively. In the RCBTB subgroup,
all three RLDs are closely related to each other, as happens with the
Kinase subgroup. Finally, the miscellaneous subgroup has no
phylogenetic basis at all, since its three members are not closely
related to each other: Alsin RLD is most similar to the RLDs of small
HERCs, PAM's RLD is closest to those in the RCBTB subgroup and the
RLD of RPGR clusters with those of RCC1 subgroup members RCC1,
TD-60 and WBSCR16.
Very little is known regarding the evolution of RLDs. The fact that
RCC1 repeats and RLDs are found in all sorts of organisms, including
prokaryotes, unicellular eukaryotes, plants, fungi and animals (as
shown by the Pfam database, entry PF00415 [18,19]), suggests a very
ancient origin for this domain, possibly previous to the appearance of
eukaryotic organisms. Nevertheless, other possibilities have been
suggested, such that prokaryotes got their RLDs later on by horizontal
gene transfer from eukaryotes [17,20]. Even less can be said about the
mechanisms that gave rise to the ﬁrst RLDs. In this respect, the fact
that exons in RCC1 roughly match its sequence repeats seems to
indicate that the RLD arose by sequential duplication of an ancestral
repeat module, but this has yet to be proven [17]. In any case,
regardless of how RLDs ﬁrst came into being, they have proven to be
very useful and versatile protein domains, as evidenced by their
widespread distribution and their conservation between species.Fig. 2.Multiple alignment of the RLDs of all known human RCC1 superfamily proteins. The se
using ClustalW and Jalview [158–160], then edited manually. Alignments are colored using
small and hydrophobic amino acids (A, V, L, I, M, F, W) in blue, hydroxyl and amine amin
positively charged amino acids (R, K) in red and histidines and tyrosines in dark blue. The
alignment [158–160]. A phylogenetic treewas generated from this alignment and is shown in
the sequences corresponding to its seven internal repeats are marked by bidirectional arrow
RCC1 β-wedge. HERC1 and HERC2, which have more than one RLD, have each of their doma
between the seven propeller blades (each in different colors also represented in the alignm3. Three-dimensional structure
To this day, only two three-dimensional structures of RLDs have
been published [15,21,22]. One of them corresponds to the bacterial
β-lactamase inhibitor protein-II (BLIP-II) from Streptomyces exfoliatus
[21], while the other is that of human RCC1 [15]. Since both structures
are remarkably similar, we will focus our discussion mainly on the
latter. Ten years ago, Renault et al. reported that the crystal structure of
RCC1 resembles that of the WD40 domain, which is present, among
others, in the beta subunits of trimeric G proteins [15]. Despite their
distinct amino acid sequences, RLD and WD40 domains share a
tertiary structure which is reminiscent of a seven-bladed propeller
[15]. In RCC1, each of these blades consists of a four-stranded
antiparallel β-sheet, with the inner strand of each blade aligned
with the central shaft of the propeller, which is ﬁlled with water
molecules [15]. Interestingly, the seven repeats identiﬁed in RCC1 by
primary sequence analysis (see above) do not correspond with the
blades of the propeller, but rather each sequence repeat contains the
third and fourth β-strands of one blade, followed by the ﬁrst and
second β-strands of the next blade [15] (inset Fig. 2). As a result of this,
one of the blades in the propeller consists of the last half of the
seventh sequence repeat, followed by the ﬁrst half of the ﬁrst
sequence repeat, an arrangement that behaves as a molecular clasp,
closing the circular structure [15]. A superimposition of all seven
blades in RCC1 shows a very remarkable structural similarity in the
ﬁrst three β-strands of each blade, suggesting that these strands are
the most essential to maintain the overall propeller structure [15].
By contrast, the fourth strand, the outermost one in each blade,
is structurally more variable, and it is likely that these strands play
a more important role in the interactions of RCC1 with other mole-
cules. Consistent with this, BLIP-II, which also folds as a seven-bladed
β-propeller, only has three β-strands per blade, conﬁrming that the
outer β-strand is not required to maintain the core propeller structure
[21]. Each of the blades in RCC1 contains several highly conserved
residues, including three glycine residues that are required for the
sharp turns between the different strands, as well as hydrophobic
residues that stabilize the antiparallel β-sheets [15]. In the outer
strands, there are also several conserved residues, including an
invariable cis-proline [15]. Both the N- and the C-terminal tails of
RCC1 are located on the same side outside the propeller plane,
with the N-terminal tail containing a nuclear localization signal
(NLS) as well as phosphorylation andmethylation sites [23–26]. While
N-terminal methylation is required for binding of RCC1's N-terminal
tail to nucleosomal DNA, core nucleosomal histones bind to the
propeller itself at the same side where N- and C-termini protrude
[23,27]. On the opposite side of the propeller, multiple Ran-binding
residues can be found, in addition to those involved in catalyzing
nucleotide exchange on this small GTP-binding protein [15]. A crit-
ical role in this latter function is carried out by the β-wedge, a rigid
β-sheet protruding prominently from blade-3 (residues 146–153),
which is directly involved in destabilizing the association between
Ran and GDP, thus eliciting GDP release and subsequent GTP uptake by
Ran [15]. As expected, no β-wedge is present in BLIP-II [21].
Given this wealth of structural data for RCC1, the question arises as
to whether RCC1's structural features are conserved in other RCC1
superfamily proteins, and to what extent. In principle, given the
sequence homology between RCC1 and the other RLDs, it would seemquences used correspond to the entries shown in Table 1. This ﬁgure has been generated
the Clustal-IX scheme in Jalview (glycines are shown in orange, prolines in lime green,
o acids (S, T, N, Q) in dark green, negatively charged amino acids (D, E) in magenta,
consensus sequence and degree of conservation (graph in black) are shown under the
Fig. 3A. The RCC1 sequence has been highlighted with a red rectangle (dashed line), and
s [15]. A red ﬁlled rectangle around sequence number 180 represents the location of the
ins numbered. In the bottom right, a schematic representation depicts the relationship
ent) of RCC1 and its seven sequence repeats [15].
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Fig. 3. (A) Phylogenetic tree of the RLDs of all human RCC1 superfamily proteins. The treewas generated using ClustalWand Jalview [158–160]. (B) Human RCC11.7 Å structure [15,22].
(top) lateral viewof theβ-propeller showing theβ-wedge, necessary for theGEFactivity of RCC1 on Ran, and theN- and C-termini of RCC1. (bottom) frontal viewof theβ-propeller. The
ﬁgure was generated and edited using the Cn3D program (www.ncbi.nlm.nih.gov/structure/Cn3D/cn3d.shtml) (Protein Data Bank entry for the human RCC1 structure is 1A12).
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following paragraphs, we will present evidence pointing in this
direction, but it must be kept inmind that deﬁnitive evidencewill only
be provided by high-resolution structural analyses like those
published for RCC1 and BLIP-II [15,21].
A ﬁrst piece of evidence favouring the hypothesis that most or all
RLDs fold as seven-bladed β-propellers lies in the fact that BLIP-II,
despite being a bacterial protein and having only four canonical RCC1
repeats (and three non-canonical ones), also adopts this same folding
[21], thus indicating that RCC1-like repeats need not be canonical in
order to give rise to the antiparallel β-sheets that constitute the
blades. In order to further test our hypothesis, we analyzed whether
critical residues needed for propeller formation in RCC1 are conserved
in the other human RLDs. There are only four residues that are
conserved in all seven repeats in RCC1: three glycines needed for the
turns between β-strands and a cis-proline in the last strand of each
blade [15]. We counted how many of these 28 residues in RCC1 were
conserved in each of the other RLDs. To do that, we scored as positive
hits those cases in which an RLD had the same residue as RCC1 in
either the same position (as deﬁned by the alignment in Fig. 2), or up
to two residues away from the expected position. Using these criteria,
we found that most RLDs (14 out of 20) contain at least 80% of the 28
studied residues in the appropriate positions. For the other six RLDs,
the values are over 70% for PAM, Nek8 and Nek9, 60% for IBtk, 50% for
Alsin, and only 35% for HERC5. Therefore, on the basis of these data
alone, HERC5, Alsin and IBtk would be the least likely candidates to
share a common three-dimensional fold with RCC1.Another hint as to whether other RLDs also fold as seven-bladed
β-propellers can be found by looking at the predicted secondary struc-
tures for these domains. We used the Hierarchical Neural Network
(HNN) secondary structure prediction method (http://npsa-pbil.ibcp.fr)
to do this for all the RLDs in Fig. 2. In all cases, these RLDs are predicted
to contain multiple β-strands at roughly the expected positions, and
these strands are almost invariably followed very closely by glycine
residues. This is true even for HERC5, Alsin and IBtk, suggesting that
our previous failure to identify these glycines is probably due to
these residues not being well aligned in Fig. 2 with their counterparts
in the other RLDs. Altogether, the observations presented here suggest
that most or all RLDs fold as seven-bladed β-propellers, although, as
has been said, deﬁnitive proof is not yet available.
Even if the overall propeller structure is broadly conserved
among these proteins, there is still room for signiﬁcant variability
among individual RLDs. As mentioned above, the RLD of RCC1
contains an extra β-sheet, also known as the β-wedge, which sticks
out of the propeller between the third and fourth β-strands of blade-
3. This β-wedge, which is critical for RCC1 function, does not appear
to be conserved in other RLDs (Fig. 2, red ﬁlled box). The existence of
the β-wedge in RCC1 proves an important point, namely that speciﬁc
structural motifs can be intercalated between the β-strands of the
propeller (at least between the third and fourth strands of a blade)
without disrupting β-propeller structure, and that these speciﬁc
motifs may bestow important functions upon the RLDs containing
them. Hence, other RLDs may also contain analogous motifs (not
necessarily similar to RCC1's β-wedge), which may confer important
1473O. Hadjebi et al. / Biochimica et Biophysica Acta 1783 (2008) 1467–1479and speciﬁc activities to these domains without affecting their
overall folding pattern. But again, more three-dimensional struc-
tures of RLDs will be needed in order to determine whether this is
the case or not.
4. Tissue and subcellular localization
While some human RLD-containing proteins, such as RCC1, have
essential cellular functions and seem to be expressed in virtually all
cell types, others, like IBtk, have more restricted expression patterns
and their functions are likely to be more tissue-speciﬁc. On the other
hand, the subcellular localizations of all these proteins are dependent
on which other molecules they interact with inside cells. In the RCC1
subgroup, RCC1 and TD-60, both of which have essential cell cycle
functions and are widely expressed, have nuclear localization signals
(NLS) [26,28,29] and are therefore located in the nucleus during
interphase (it must be noted, however, that TD-60 is only expressed in
the G2 and M phases of the cell cycle [30], while RCC1 levels are cell
cycle-independent). By contrast, during cell division RCC1 is asso-
ciated with mitotic chromosomes [24,29], whereas TD-60 is asso-
ciated with the inner centromeres, from which it migrates to the
spindle midzone at later stages of mitosis [28]. While the RLD plays an
important role in RCC1's association to chromatin [23,27,31], nothing
is known about how TD-60 interacts with centromeres and themitotic
spindle. Likewise, not much is known about the two other RCC1
subgroup members, DelGEF and WBSCR16, other than the fact that
DelGEF has two isoforms, one of which (DelGEF1) is located primarily
in the nucleus, but also in the cytoplasm, whereas the other (DelGEF2,
having a truncated RLD) seems to localize in mitochondria [8,32,33].
Concerning the HERC subgroup, all members are expressed in most if
not all tissues, but at varying levels. Thus, HERC1, HERC2, HERC4 and
HERC6 mRNAs are especially abundant in brain and testis [4,7,34],
HERC3 is more prevalent in brain [7,35] and HERC5 is expressed at
much higher levels in testis than in any other tissue [7,36,37]. In
addition, HERC5 and HERC6 levels in certain cell types have been
shown to be regulated by inﬂammatory mediators, but this will be
dealt with in the following section [37–40]. In terms of their
intracellular localizations, these proteins seem to be cytosolic,
although they can also be found associated to intracellular membranes
by virtue of their interactions with other proteins or lipids [4,5,7,41–
45]. Regarding the kinase subgroup, Nek9 appears to be a ubiquitous
mitotic regulator, whereas Nek8 mRNA is more abundant in liver,
kidney and testes, although it is also present in other tissues [46].
There is some controversy as to whether Nek9 is located mainly in the
nucleus or the cytosol [47–49]. In any case, however, it is clear that
Nek9 has an NLS and the nuclear-to-cytoplasm ratio of the protein can
be affected by the adenoviral E1A protein [49]. On the other hand,
Nek8 has been shown to reside in the cytoplasm and in the proximal
region of primary cilia in kidney epithelial cells [50,51]. Not much is
known about the localization of RCBTB subgroupmembers, apart from
the fact that IBtk seems to be speciﬁcally expressed in lymphocytes,
where it is found underlying the plasma membrane [52]. As to the
miscellaneous subgroup, an interesting case is that of RPGR, for which
several isoforms have been reported [9,11,12]. Apart from a recently
described isoform which predominates in the inner segments of
retinal cones and whose RLD is slightly truncated [11], the two main
RPGR isoforms seem to be RPGRex1–19 and RPGRORF15. Both share the
same RLD but differ in their C-termini, where RPGRORF15 has a
glutamic acid-rich domain and a nucleophosmin-binding domain that
are absent in RPGRex1–19 [9,53]. Both isoforms associate with
microtubule-containing structures such as the connecting cilia of
retinal photoreceptors, where RPGRORF15 predominates [54], or the
transitional zone of motile cilia in airway epithelia, where only
RPGRex1–19 can be found [54]. In addition, RPGRORF15 localizes to
centrosomes/spindle poles in cultured cell lines that lack cilia as well
as in the basal body in ciliated cell lines [53]. RPGRORF15 can also befound in the tip and axoneme of sperm ﬂagella [55]. Although RPGR
interacts with a number of different proteins, the RLD-mediated
interaction of RPGR with RPGRIP is of critical importance to target
RPGR to the photoreceptor connecting cilium [56]. Regarding the Alsin
protein, its levels have been found to be highest in brain, but other
tissues also contain smaller amounts of the protein [57]. Alsin has
been localized to multiple sites within the cell: the cytosol, endocytic
compartments, including early endosomes and macropinosomes,
and actin-rich structures such as membrane rufﬂes and lamellipodia
[57–59]. Interestingly, the RLD of Alsin seems to prevent binding
to these membrane-bound compartments, maybe because of an
intramolecular interaction between the N-terminal RLD and the
C-terminus of the protein [59]. Finally, PAM is expressed ubiqui-
tously but with higher mRNA levels in brain and thymus [60]. In
mouse and rat brains, mRNA levels of the respective PAM orthologs
are most abundant in the pyramidal cells of the hippocampus and in
the granule cells of the dentate gyrus and cerebellum [61]. PAM
expression is also developmentally regulated, with mRNA levels
increasing in mouse in the two weeks immediately after birth, until
they reach adult levels [61]. At the subcellular level, PAM has been
found to reside in the nucleus, but it is also present in the cytosol and
in the neurites of nerve cells [60,62,63].
5. Functions
At the functional level, RCC1 is undoubtedly the best characterized
member of the family. RCC1 is a guanine nucleotide exchange factor
(GEF) for Ran (Ras-related nuclear) [for review on GEFs, see [64]]. The
fact that Ran-GEF, i.e. RCC1, is in the nucleus whereas Ran-GAP (Ran
GTPase activating protein) is in the cytoplasm gives rise to a gradient
of the active form of Ran that acts as the driving force behind vectorial
nucleocytoplasmic transport [65]. By contrast, during cell division the
same gradient is established around mitotic chromosomes, to which
RCC1 binds by means of its interaction with DNA and histones
[23,27,31,66], an interaction that allosterically regulates RCC1's GEF
activity [31]. This mitotic gradient, in turn, has a critical role ﬁrst in
mitotic spindle formation and then in nuclear envelope reassembly
[67,68]. Unlike other RLD-containing proteins, RCC1 seems to be
present in all eukaryotic organisms, including the baker's yeast
Saccharomyces cerevisiae, where it is known as Prp20p or Srm1 [69–73],
and the ﬁssion yeast Schizosaccharomyces pombe, where its name is
Pim1 [74,75]. These RCC1 orthologs seem to be the only RLD-containing
proteins in these organisms, and their functions appear to be very
similar to theirmammalian counterparts, as shownby the fact that these
proteins also act as GEFs for the yeast orthologs of Ran [69–75]. Also
consistent with a broad evolutionary conservation of RCC1's functions,
both Prp20p and Bj1 (fruit ﬂy's RCC1) can rescue the phenotype of
RCC1 mutation in hamster cells [70]. This high degree of conservation
suggests that functions so far only ascribed to some of the RCC1
orthologs, such as the role of Prp20p in nuclear pore complex (NPC)-
mediated transcriptional control [76], may also be conserved in other
organisms, although this remains to be proven.
Not so much is known about the other RLD-containing proteins.
TD-60 is a member of the chromosome passenger complex (CPC) in
inner centromeres and plays an essential role in prometaphase to
metaphase progression [28], where it is required for proper localiza-
tion of other CPC proteins (INCENP and Aurora B), for Aurora B kinase
activation together with microtubules and for proper alignment of
chromosomes on the metaphase plate [28,77]. TD-60 also seems to
play a role in cytokinesis, but the mechanisms are not yet clear [30]. In
addition, TD-60 has been shown to interact preferentially with the
nucleotide-free form of Rac1, suggesting that TD-60 might be a Rac1-
GEF, although this has not been demonstrated [28]. DelGEF regulates
proteoglycan secretion by binding to DelGIP1 (DelGEF Interacting
Protein 1) and to the exocyst component Sec5 [32,33], whereas
WBSCR16 (also known as WBS16) is yet to be studied.
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terminus) domain and at least one RLD (for review see [5]). The
HECT domain of these proteins is believed to be involved in the
transfer of ubiquitin or ubiquitin-like proteins to target substrates
[78]. In this respect, HERC5, whichwas initially described as Ceb1 [36],
has been found to catalyze the transfer of ISG15 (interferon-
stimulated gene-15), a protein related to ubiquitin, to a number of
cellular proteins in response to interferon-α/β [38–40]. Moreover,
HERC5 activity as an ISG15 ligase has been shown to be abolished both
by mutation of the active site cysteine (Cys-994) in the HECT domain
and by deletion of the RLD [38,39]. Apart from that, HERC5 mRNA has
been shown to be induced by a number of inﬂammatory mediators,
including LPS, TNF-α, IL-1β and IFN-α/β [37–39], whereas HERC5
protein levels are downregulated in response to LPS [37]. The HERC5
protein also interacts with both cyclin E and p21 and its levels rise in
response to compromised p53 or retinoblastoma (Rb) activity, which
suggests a role in the cell cycle [36]. Whether or not the roles of HERC5
in inﬂammation and the cell cycle are connected with each other has
not been established yet. Interestingly, the HERC5 gene has only been
found in primates, so it is unclear whether its functions are primate-
speciﬁc or, alternatively, they are performed in other species by its
close homolog HERC6 [7]. Consistent with the latter hypothesis,
HERC6 is present in rodents and is also regulated by interferon-β
[7,38].
HERC1, formerly known as p532, has been shown to bind to the
tumor suppressor TSC2 and it has been suggested that HERC1 could be
involved in TSC2 ubiquitination, but this has not been proven [79]. On
the other hand, in vitro studies have shown that the HECT domains of
both HERC1 and HERC3 form covalent thioester bonds with ubiquitin,
suggesting that they have E3 ubiquitin ligase activity, but no target has
been found in either case [41,80]. Furthermore, the RLD1 of HERC1 has
been shown to associate with phosphatidylinositol-4,5-bisphosphate
(PI(4,5)P2), an interaction that is required for the ability of this domain
to act as a guanine nucleotide release factor (GRF) for small GTP-
binding proteins of the ARF and Rab families [4,42]. In addition,
binding of the RLD1 to PI(4,5)P2 has been suggested to be responsible
for the recruitment of HERC1 onto actin-rich membrane protrusions
[43]. HERC1 RLD2, on the other hand, interacts directly with clathrin
heavy chain (CHC), which suggests a role for HERC1 in vesicular
transport [44]. Although no biochemical studies exist concerning the
function of HERC2, the phenotype of HERC2 mutant mice suggests a
possible role for this protein in either vesicular trafﬁcking or the cell
cycle of speciﬁc cell types, but this awaits demonstration [34].
Regarding HERC3, in addition to having an active HECT domain
[41,80], this protein has been shown to undergo ubiquitin-mediated
proteasomal degradation and to non-covalently interact with ubiqui-
tin [41]. However, even though its intracellular localization suggests a
role in vesicular trafﬁcking, nothing is yet known about the precise
function of this protein [41]. Since HERC3 is most closely related to
HERC4, it is possible that both proteins share similar functions. HERC4
has recently been identiﬁed as an important player in spermatogen-
esis [45]. More precisely, the absence of HERC4, which is normally
expressed in all sperm cell precursors but not in mature spermatozoa,
causes a signiﬁcant reduction in sperm cell motility, which is due to
incomplete clearance of proteins and organelles from sperm cell
precursors, resulting in abnormal ﬂagella in the mature sperm [45].
Although it seems very likely that the role of HERC4 in spermatogen-
esis is based on its ubiquitin ligase activity, this has not been
demonstrated [45].
In the kinase subgroup, Nek9 is a p34/Cdc2 substrate with critical
roles in cell cycle progression, both during interphase [47] and during
mitosis [48,81]. In addition, Nek9 binds to Ran through both its RLD
and kinase domains, but Ran-GEF activity like that of RCC1 has not
been demonstrated [48] and it is thought to be unlikely given the
relatively low similarity between the RLDs of both proteins [48].
Instead, the RLD of Nek9 is thought to play an autoinhibitory role bydirect binding to the kinase domain [48,82,83]. Finally, the C-terminus
of Nek9 has been shown to interact with Nek6 and Nek7, two
members of the Nek family of kinases that, unlike Nek8 and Nek9, do
not have RLDs [81]. In contrast to the cell cycle function of Nek9, Nek8
appears to regulate primary cilia length in kidney epithelial cells [84],
which in turn may be a consequence of Nek8's ability to affect the
phosphorylation status of other proteins, such as polycystin-2, a ciliary
protein [85], or Bicd2, a protein involved in microtubule-dependent
transport [50,86]. In the RCBTB subgroup, IBtk acts as an inhibitor of
Bruton's tyrosine kinase (Btk) in lymphocytes [52], but nothing else is
known about these proteins.
Concerning the last subgroup, Alsin was initially reported to act as
a GEF for Rab5, via its Vps9 domain, and for Rac1, via its DH–PH
domain [58]. Nevertheless, while the role of Alsin as Rab5-GEF seems
to have stood the test of time, the same cannot be said for its
purported Rac1-GEF activity, which is a source of controversy [59].
Indeed, a recent report suggests that Alsin acts as a downstream
effector of active Rac1, rather than as a Rac1 upstream activator [59].
According to this study, Rac1 activation recruits Alsin to membrane
rufﬂes and macropinosomes, which in turn leads to Alsin-mediated
Rab5 activation and subsequent Rab5-dependent fusion of macro-
pinosomes with other endosomes. Further evidence favouring a role
for Alsin in the control of endocytic events comes from a number of
additional studies [87–89]. In particular, Alsin's RLD has been shown
to bind to GRIP1 (Glutamate receptor-interacting protein-1) and
thereby control surface expression of AMPA-type glutamate receptors
in neurons [89]. Moreover, neurons from Alsin−/−mice show defects in
ligand-induced TrkB and IGF-1R endocytosis, which may be due to
faulty Rab5-dependent endosome fusion [88]. Finally, Alsin's RLD has
been shown to interact with the C-terminal half of Alsin (encompass-
ing its MORN and Vps9 domains) and this has been proposed to play a
role in the regulation of Alsin's translocation to the plasmamembrane,
but this remains unproven [59].
Concerning RPGR, mounting evidence suggests that it has an
important role in regulating microtubule-dependent transport along
cilia (see [9] for review). First of all, RPGR is located in cilia in different
tissues (see Tissue and subcellular localization) and interacts, directly
or indirectly, with a number of axonemal and basal body proteins, as
well as with microtubule motor proteins [9,53,55,90–93]. Moreover,
mutations in RPGR lead to malfunction of cells/tissues that depend on
ciliary function for their proper operation, such as retinal photo-
receptors (which require transport along their connecting cilia in
order to properly assemble the light-capturing discs on their outer
segments), airway epithelia or sensory cells in the cochlea (see
Involvement in diseases). Apart from this, RPGR has been shown to
associate, via its RLD, with the delta subunit of rod cGMP-
phosphodiesterase, but the functional signiﬁcance of this interaction
is not entirely clear [94].
As its name reveals, PAM (protein associated with Myc) was
identiﬁed by virtue of its binding to the transcriptional activation
domain of Myc [60]. More recently, alternative splicing of PAM has
been shown to regulate its binding afﬁnity for this transcription factor
[10]. The PAM–Myc interaction takes place in the nucleus, where PAM
is enriched [60], and, although nothing is known about the functional
signiﬁcance of this interaction, a possible role is suggested by the fact
that PAM is downregulated in quiescent and senescent ﬁbroblasts
relative to replicative ones [95]. Apart from the nucleus, PAM is also
found in the cytoplasm, where it has been shown to act as a potent
inhibitor of certain adenylyl cyclase (AC) isoforms [96]. In particular,
when HeLa cells are treated with sphingosine-1-phosphate, PAM
translocates from the endoplasmic reticulum to the plasma mem-
brane and this results in a long-lasting inhibition of AC and of agonist-
stimulated cAMP accumulation [97]. Remarkably, the RLD of PAM is
sufﬁcient for AC inhibition [96], and different residues within the RLD
have been implicated in AC binding and inhibition, respectively [98].
In addition to its roles in the nucleus and in controlling cAMP-
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role for the murine ortholog of PAM in the male germline is suggested
by the fact that PAM mRNA contains a 26-nucleotide sequence that
binds to DAZL, a germ cell-speciﬁc protein with an essential role in
sperm production [99]. Although this suggests that PAM protein
translation might be regulated during spermatogenesis [100], this has
not been demonstrated. By contrast, plenty of evidence shows that
PAM and its orthologs have a conserved role in neuronal development
and function (for a review, see [101]). In mammals, apart from its
higher expression in speciﬁc parts of the brain [61] and its role in
spinal nociceptive processing, which may be dependent on AC
inhibition [102], PAM (known as Phr1 in mouse) has recently been
found to play an important role in motor axon navigation in the
developing embryo [62]. This function has been connected with Phr1's
ability to downregulate DLK, a MAPKKK, and thus block p38 MAPK
signaling within axon shafts, which in turn controls the microtubule
cytoskeleton [62]. These ﬁndings are consistent with previous results
suggesting that Phr1 deletion underlies defects in respiratory muscle
innervation leading to death of newborn mice [103] (see Involvement
in diseases). Furthermore, PAM has been found to colocalize and
interact with the TSC1/TSC2 tumor suppressor complex in the neurites
and growth cones of brain cortical neurons [63]. This interaction is
likely to be evolutionarily conserved, since the Drosophila and
zebraﬁsh orthologs of PAM have also been shown to functionally
interact with this complex [63,104]. In zebraﬁsh, PAM ortholog Esrom
is required for the bundling and targeting of retinal axons [104] as well
as for tetrahydrobiopterin and yellow pigment production [105]. In
Drosophila, mutations in the PAM ortholog Highwire lead to increased
synaptic growth but also to impaired synaptic function [106,107]. This
phenotype is similar to the one observed in C. elegans when RPM-1,
the worm ortholog of PAM, is mutated [108,109]. Indeed, recent
studies have shown that both Highwire and RPM-1 control synapto-
genesis in part by inducing the ubiquitination and subsequent
degradation of target proteins in the synapse [110–116]. In the
nematode, RPM-1 has been shown to be a constituent of a synaptic
SCF-like ubiquitin ligase complex including Skp1, Cullin and the F-box
protein FSN-1, with which RPM-1 interacts [114]. This complex
regulates synaptic cytoarchitecture by mediating the degradation of
DLK-1, a MAPKKK, and thereby suppressing signaling through a MAPK
cascade involving DLK-1, MKK-4 (MAPKK) and PMK-3 (a p38 MAPK)
[115]. Much of this pathway seems to be conserved in the ﬂy (and
probably in mouse also, see above), where Highwire also collaborates
with DFsn (FSN-1 ortholog) [113] to induce degradation of Wallenda/
DLK (DLK-1 ortholog) [112]. However, instead of suppressing a p38
MAPK cascade like RPM-1 does, Highwire suppresses activation of JNK
and of the Fos transcription factor [112]. Nevertheless, suppression of
MAPK signaling only explains part of the synaptic defects of RPM-1/
Highwire loss-of-function mutants [107,112,116,117]. Thus, Highwire
also acts by suppressing BMP signaling, which it probably achieves by
inducing the ubiquitin-mediated degradation of the co-Smad protein
Medea [117]. On the other hand, other downstream targets of RPM-1
include the GLO-4/GLO-1 pathway [116] and possibly the receptor
tyrosine kinase ALK [114]. Interestingly, the N-terminal half of RPM-1,
which includes its RLD but not its RING ﬁnger necessary for ubiquitin-
dependent functions, has been shown to interact with GLO-4, itself an
RLD-containing protein which in turn regulates the function of a Rab
GTP-binding protein named GLO-1 [116]. This RPM-1/GLO-4/GLO-1
pathway, which acts in parallel with the RPM-1/DLK-1/MKK-4/PMK-3
one, regulates synaptic physiology by affecting late endosome
function [116]. Although GLO-4, a protein most closely related to
RPGR, DelGEF and Drosophila Claret, is a candidate GLO-1-GEF, this has
not been demonstrated [116].
To ﬁnish this section, the available information on RCC1 super-
family proteins lacking clear mammalian orthologs will be brieﬂy
reviewed. As has been said, GLO-4 is most closely related toDrosophila
Claret. Both GLO-4 and Claret have been shown to act upstream of Rabproteins (GLO-1 and Lightoid, respectively) and both are needed for
the formation of lysosome-related organelles (gut granules in the case
of GLO-4, eye pigment granules in the case of Claret) [118,119]. In
addition, the RLD of Claret has been shown to bind preferentially
to the nucleotide-free form of Lightoid, suggesting that Claret may
act as a Lightoid-GEF. Whether Claret/Lightoid share the function of
GLO-4/GLO-1 at the synapse remains to be determined. PARF-1 is an
Arabidopsis thaliana protein containing PH, RLD and FYVE domains
that has been shown to bind monophosphorylated phosphoinositides
[120]. UVR8 (UV-resistance locus-8) is another Arabidopsis protein
that, like RCC1, consists of a canonical RLD ﬂanked by short N- and
C-terminal tails (curiously, though, the closest mammalian homolog of
UVR8 RLD is the RLD of HERC4, which is 38% identical). UVR8
accumulates in the nucleus in response to UV-B light and orchestrates
the plant UV response by binding to chromatin via histones and
inducing the expression of downstream genes such as HY5 and those
involved in ﬂavonoid biosynthesis [121–123]. Nd6p (non-discharge
protein-6) is found in the protozoon Paramecium tetraurelia and
presents two RLDs on its N-terminus [124]. Nd6p is required for dense
core granule exocytosis and the RLDs seem to be essential for this
function [124]. In bacteria, the Pfam database ﬁnds 65 proteins with
canonical RCC1 repeats. Although none have been described yet, it will
be interesting to see what proteins like Q74DR4 (Swissprot accession
number), with more than 2000 amino acid residues and six RCC1
repeats in its N-terminus, are doing in bacteria such as Geobacter
sulfurreducens [18,19]. Even a fewviruses seem to contain RLDproteins,
as is the case for neseORF72 and neseORF73, found in Neodiprion
sertifer nucleopolyhedrovirus [18,19].
6. Involvement in diseases
Mutations in RCC1 superfamily proteins have been linked to
several diseases. Among these, one of the best studied cases is that
of RPGR, mutations of which are responsible for 70–80% of cases of
X-linked retinitis pigmentosa (XLRP), one of the most severe forms of
human retinal degeneration [9]. More than 200 disease-causing
mutations have been identiﬁed in RPGR, many of them affecting its
RLD. The vast majority of RPGR mutations (∼95%) lead to XLRP,
whereas the remaining 5% include other kinds of retinal degeneration
and also, in four cases, ciliary dyskinesia, a disease whose symptoms
include upper respiratory tract and middle ear infections as well as
hearing loss [9]. All these phenotypes, together with the functional
data reviewed above, are consistent with a role for RPGR in
microtubule-dependent transport along cilia [9].
Alsin was discovered as the gene encoded by the ALS2 locus,
which had been linked to an autosomal recessive form of juvenile-
onset amyotrophic lateral sclerosis (jALS) [125,126]. To this day, ten
disease-causing mutations have been identiﬁed in the Alsin gene, all
of which lead to the production of truncated proteins (see [127,128]
for reviews). Interestingly, in those cases where truncations are very
early in the protein, affecting its RLD domain, these mutations lead to
jALS, a condition where both upper and lower spinal cord moto-
neurons degenerate. By contrast, less severe truncations in Alsin lead
to either juvenile primary lateral sclerosis (jPLS) or to infantile-onset
ascending hereditary spastic paraplegia (IAHSP), inwhich only upper
motoneurons are affected [127]. Surprisingly, Alsin−/− mice do not
show obvious motor deﬁcits [129,130], but their neurons appear to
be more susceptible to oxidative stress [129]. In this regard, a critical
connection between Alsin, oxidative stress and ALS may lie in the
fact that Alsin binds to Cu/Zn superoxide dismutase (SOD1), the
protein encoded by the ALS1 locus involved in autosomal dominant
ALS [131,132]. Furthermore, Alsin has been shown to antagonize the
neurotoxic effects of dominant SOD1 mutants, an activity for which
the DH–PH domain of Alsin is essential [131,132]. Finally, Alsin−/−
mice have recently been shown to have lymphopenia and other
hematopoietic abnormalities resembling those also observed in ALS
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deﬁciency in the ethiopathogenesis of ALS, this is not yet clear.
Another RLD-containing protein involved in disease is Nek8. In
addition to being overexpressed in human breast tumors [135], a
mutation in the RLD of Nek8 (G448V) was found to underlie a form of
murine autosomal recessive polycystic kidney disease (PKD) known as
juvenile cystic kidney, or jck [46,136]. Nek8 localization to cilia is lost in
the renal epithelia of these animals, which results in structurally
abnormal cilia and leads to cyst formation [84,137]. Although little is
known about the detailed mechanisms controlling cystogenesis, this
process appears to be regulated by a pathway involving both Nek8 and
Pkd1, another protein involved in PKD [138]. On the other hand,
mutations in human Nek8 have very recently been identiﬁed as the
cause of nephronophthisis type 9, a juvenile renal cystic disease [139],
and it has been suggested that Nek8might also be linked to human PKD
[140].
Also involved in mouse pathology is HERC2, mutations of which
lead to the rjs syndrome (runty, jerky, sterile), also known as jdf2
(juvenile development and fertility-2) [34,141,142]. Although the
pathogenic mechanisms of this syndrome are not known, it has been
suggested that at least some of its symptoms could be due to pituitary
defects [34]. In humans, the HERC2 genomic locus, including multiple
partially duplicated paralogs of HERC2 [143], corresponds to the
chromosomal breakpoint region in deletions causing Prader–Willi and
Angelman syndromes [144,145]. However, lack of HERC2 protein
does not seem to play a role in any of these syndromes [142]. Like-
wise, in a very recent set of papers, a single nucleotide polymorphism
(SNP) in intron 86 of the HERC2 gene has been shown to determine
human blue/brown eye color, but this intronic sequence has its
effects by controlling the expression of the neighboring OCA2 gene
[146–148].
Concerning other HERC proteins, HERC1 was found during the
course of a screen aimed at identifying mammary oncogenes and was
shown to be overexpressed in tumor cell lines relative to normal ones
[4]. More recently, HERC1 has been shown to bind to the tumor
suppressor TSC2 [79]. However, in spite of these data, it remains
unclear whether HERC1 plays any role in tumorigenesis.
On the other hand, HERC5 seems to be an important player in the
innate immune response [37–39]. Initially, HERC5 expression in
endothelial cells was found to be tightly modulated by proinﬂamma-
tory cytokines such as TNF-α and IL-1β and by the bacterial
lipopolysaccharide (LPS), suggesting a role for HERC5 in inﬂammation
and bacterial infections [37]. More recently, HERC5 levels have also
been shown to be upregulated by type I interferons, which are them-
selves expressed in response to bacterial or viral infections [38,39].
Furthermore, it has been shown that, in response to interferonsα or β,
HERC5 catalyzes conjugation of ISG15, a ubiquitin-like protein, to a
broad spectrum of target proteins [38–40]. Although the exact
function of ISG15 conjugation, also known as ISGylation, to target
proteins is not yet known, it seems clear that this is an important
innate defensive mechanism, as supported by the fact that a viral
protein, NS1 from inﬂuenza B virus, has developed the ability to
speciﬁcally block ISGylation [149,150].
Apart from the possible presence of anti-PAM autoantibodies in
some schizophrenic patients [151], no evidence exists that PAM is
involved in any human disease. Nevertheless, Phr1, the murine
ortholog of PAM, is the best candidate for a respiratory distress syn-
drome that kills mice at birth [100]. In these mice, the phrenic nerve
fails to completely innervate the diaphragm, whereas the intercostal
muscles, though innervated, show dysmorphic nerve terminals [100].
This phenotype is consistent with both the evolutionarily conserved
role of Phr1 orthologs in synaptic development [110,112–115] and its
effects on motor axon navigation in the embryo [62]. Interestingly,
Hirschsprung's disease in humans is often accompanied by congenital
central hypoventilation syndrome and it has been proposed that this
might be due to genomic deletions encompassing not only the Ednrbgene (responsible for Hirschprung's disease) but also the neighboring
PAM gene [100].
WBSCR16,whose name comes from the fact that the gene is located
in theWilliams–Beuren syndrome (WBS) critical region, is one ofmany
genes at 7q11.23 one copy of which is deleted in this neurodevelop-
mental disorder. WBS is thought to arise as a result of haploinsufﬁ-
ciency of multiple genes in this region and the precise contribution, if
any, of WBSCR16 to the WBS phenotype is not known [152].
DelGEF was thus named because of its genomic location in a
deafness locus (DFNB18) and its assumed role as a GEF. While there is
no evidence of DelGEF having GEF activity, it has been proven that the
gene responsible for non-syndromic recessive deafness (DFNB18) is
not DelGEF, but USH1C [153]. Therefore, there is no evidence
connecting DelGEF with any human disease.
Finally, the RCBTB1 and 2 genes, formerly CLLD7 and CHC1L
respectively, are located very close to each other in chromosomal band
13q14. RCBTB1 is a candidate tumor suppressor gene for B-cell chronic
lymphocytic leukemia (B-CLL) [154–156], whereas RCBTB2 might be a
tumor suppressor in sporadic prostate cancer [157].
7. Conclusions
The initial identiﬁcation of RCC1 as the guanine nucleotide
exchange factor (GEF) for Ran led many to assume that RCC1-like
domains (RLDs) in other proteinswould also act as GEFs for small GTP-
binding proteins. Although this is clearly the case for other domains
with GEF activity [64], it does not seem to hold true for RLDs. Indeed, it
is becoming clear that different RLDs, rather than sharing a conserved
function, share a very versatile conserved structure that has been co-
opted by a number of proteins to perform many different functions.
Most often, RLDs participate in protein–protein interactions. These
interactions do sometimes involve small GTP-binding proteins, but
only in the case of RCC1 has GEF activity been shown conclusively.
Although someotherRCC1 superfamily proteins are certainly goodGEF
candidates (e.g. Claret and GLO-4), it remains a mystery how many of
them will eventually turn out to be bona ﬁde GEFs. In other cases,
binding of an RLD to a target protein may affect protein localization
(e.g. RPGR targeting to the connecting cilium depends on its RLD
binding to RPGRIP) or may affect the activity of the target protein (e.g.
PAM's RLD inhibiting adenylyl cyclase activity). Apart from binding to
other proteins, RLDs have also been shown to bind to lipids (the case of
HERC1), which underscores the functional versatility of this domain.
It has been more than twenty years since RCC1 was originally
identiﬁed. Over these two decades, all human RCC1 superfamily
proteins, and many non-human ones, have been discovered and most
of them are characterized to some extent. In practically all cases,
however, the functions of these proteins are only beginning to be
understood, which guarantees many fascinating discoveries for the
near future.
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